S 250 · 117th Congress
Fairness in Orphan Drug Exclusivity Act
<p><b>Fairness in Orphan Drug Exclusivity Act</b></p> <p>This bill limits which orphan drugs may be granted a market exclusivity period by the Food and Drug Administration (FDA). (Generally, an orphan drug is one that is not economically viable because of the rarity of the disease that it treats; the sponsor of an…
- Sponsor
- Cassidy, Bill (R-LA)
- Introduced
- 2021-02-04
- Policy area
- Health
- Latest action
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Digging through Congress... 🔍